ICLUSIG Ponatinib Tablets is the trade name for the generic drug ponatinib , Get MRP , ICLUSIG Reviews, Side effects , Discount Cost , MedsDelta Worldwide supplier of all Cancer drugs
Iclusig (ponatinib) is indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy. ICLUSIG (ponatinib) tablets should be administered under the supervision of a qualified physician experienced in the uses of cancer chemotherapeutic agents.
http://www.medsdelta.com
http://bit.ly/2w9HsTl

Advertisements